3107530-08-2

DOTA-C1-FAP-2286 Chemical Structure
3107530-08-2

Chemical Structure

DOTA-C1-FAP-2286

  • CAS No.: 3107530-08-2
  • Formula:C73H109N15O26S5
  • Molecular Weight:1773.06

InChIKey: QSBCTGULVNSZJA-NCAZIDMLSA-N

SMILES: OC(CN(CCN1CC(O)=O)CCN(CCN(CC1)CC(O)=O)CC(N[C@@H](CS(=O)(O)=O)C(N[C@@H](CS(=O)(O)=O)C(NCCSCC2=CC(CSC[C@H](N3)C(O)=O)=CC(CSC[C@@H](C(N4[C@](CCC4)([H])C(N5[C@@](C(N[C@H](C(N[C@H](C(N[C@H](C3=O)CC6=CC=CC=C6)=O)CCC(N)=O)=O)[C@@H](C)O)=O)([H])CCC5)=O)=O)NC(CCCCC)=O)=C2)=O)=O)=O)=O

Biological Activity: DOTA-C1-FAP-2286 is a cysteic acid-modified fibroblast activation protein (FAP)-targeting radioligand. DOTA-C1-FAP-2286 binds competitively to FAP with an IC50 of 127.64 nM. DOTA-C1-FAP-2286 is targeted accumulation in FAP-expressing cells and exhibits accelerated renal clearance. DOTA-C1-FAP-2286 can be used as a PET/CT tracer in cancer[1].

Cat. No. Product Name Purity Description Pricing
HY-P11602
DOTA-C1-FAP-2286 DOTA-C1-FAP-2286 is a cysteic acid-modified fibroblast activation protein (FAP)-targeting radioligand. DOTA-C1-FAP-2286 binds competitively to FAP with an IC50 of 127.64 nM. DOTA-C1-FAP-2286 is targeted accumulation in FAP-expressing cells and exhibits accelerated renal clearance. DOTA-C1-FAP-2286 can be used as a PET/CT tracer in cancer.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References